|
KLHL28 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.767800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.933200E-01 |
| Normal-vs-Stage2 |
9.544400E-01 |
| Normal-vs-Stage3 |
2.758400E-02 |
| Normal-vs-Stage4 |
6.011600E-02 |
| Stage1-vs-Stage2 |
6.562400E-01 |
| Stage1-vs-Stage3 |
5.978300E-04 |
| Stage1-vs-Stage4 |
7.277700E-03 |
| Stage2-vs-Stage3 |
1.974040E-01 |
| Stage2-vs-Stage4 |
2.267600E-01 |
| Stage3-vs-Stage4 |
9.752600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.216600E-01 |
| Normal-vs-AfricanAmerican |
5.017900E-02 |
| Normal-vs-Asian |
3.903000E-01 |
| Caucasian-vs-AfricanAmerican |
6.684200E-02 |
| Caucasian-vs-Asian |
4.343000E-01 |
| AfricanAmerican-vs-Asian |
1.095370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.824400E-01 |
| Normal-vs-Female |
5.734200E-01 |
| Male-vs-Female |
9.239800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.627000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.695000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.525990E-01 |
| Normal-vs-Age(81-100Yrs) |
1.147780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.420200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.921000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.687400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.056300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.868040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.432200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.759600E-02 |
| Normal-vs-Grade 2 |
2.894800E-01 |
| Normal-vs-Grade 3 |
4.202100E-02 |
| Normal-vs-Grade 4 |
2.019900E-02 |
| Grade 1-vs-Grade 2 |
3.719200E-01 |
| Grade 1-vs-Grade 3 |
2.420600E-03 |
| Grade 1-vs-Grade 4 |
1.263950E-02 |
| Grade 2-vs-Grade 3 |
4.816400E-04 |
| Grade 2-vs-Grade 4 |
1.996520E-03 |
| Grade 3-vs-Grade 4 |
2.621000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.595900E-02 |
| Normal-vs-ccB subtype |
1.263620E-01 |
| ccA subtype-vs-ccB subtype |
3.000300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.330800E-01 |
| Normal-vs-N1 |
1.291560E-02 |
| N0-vs-N1 |
2.053900E-02 |
|
|
